The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer? (Q41446217)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 22, 2010

edit

Language	Label	Description	Also known as
English	The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer?	scientific article published on November 22, 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

title

The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer? (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

main subject

retinoblastoma genes

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

author name string

Kay F. Macleod

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

language of work or name

English

0 references

publication date

22 November 2010

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

full work available at URL

http://www.jci.org/articles/view/45406/files/pdf

file format

PDF

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

http://www.jci.org/cgi/content/abstract/120/12/4179

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

http://www.jci.org/cgi/reprint/120/12/4179.pdf

file format

PDF

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

http://www.jci.org/cgi/content/full/120/12/4179

file format

HTML

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

https://europepmc.org/articles/PMC2993607

file format

HTML

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

https://europepmc.org/articles/PMC2993607?pdf=render

file format

PDF

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

https://doi.org/10.1172/jci45406

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21099103

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21099103

retrieved

1 September 2024

published in

Journal of Clinical Investigation

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

volume

120

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

issue

12

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

page(s)

4179-4182

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

cites work

The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Molecular genetics of prostate cancer: new prospects for old challenges

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Integrative genomic profiling of human prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Emerging roles of E2Fs in cancer: an exit from cell cycle control

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Proapoptotic function of the retinoblastoma tumor suppressor protein

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Cellular mechanisms of tumour suppression by the retinoblastoma gene.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Mutations and altered expression of p16INK4 in human cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

The retinoblastoma protein and cell cycle control

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Mutation and cancer: statistical study of retinoblastoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

1 October 2017

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

19 August 2018

E2F4 loss suppresses tumorigenesis in Rb mutant mice.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

19 August 2018

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993607

retrieved

19 August 2018

Identifiers

DOI

10.1172/JCI45406

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

PMC publication ID

2993607

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

PubMed publication ID

21099103

1 reference

stated in

Europe PubMed Central

PMC publication ID

2993607

retrieved

30 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41446217&oldid=2241653013"